2011
Dipyridamole-Associated Shock and Pulmonary Edema
Dioverti M, Fishman R, Moskowitz R, Arias SA, Nair S, Lall P, Schussheim AE, Zarich S, Manthous C. Dipyridamole-Associated Shock and Pulmonary Edema. Annals Of Pharmacotherapy 2011, 45: 1027-1027. PMID: 21672887, DOI: 10.1345/aph.1p734.Peer-Reviewed Original ResearchMeSH KeywordsAgedDipyridamoleFemaleHumansInfusions, IntravenousMyocardial Perfusion ImagingPulmonary EdemaShockTreatment OutcomeVasodilator AgentsConceptsNoncardiogenic pulmonary edemaDipyridamole myocardial scintigraphyPulmonary edemaSevere pulmonary edemaCardiopulmonary collapseMyocardial scintigraphyNew left ventricular dysfunctionPositive end-expiratory pressureObjective causality assessmentLeft ventricular dysfunctionEnd-expiratory pressureMechanism of shockFulminant shockInvasive ventilationMultiple vasopressorsCardiovascular collapseHypovolemic shockShock refractoryCase seriesDipyridamole infusionEchocardiography resultsEndotracheal intubationIntravenous dipyridamoleContinuous infusionIntravenous infusion
1998
Antithrombotic therapy and venous graft disease.
Schussheim AE, Fuster V. Antithrombotic therapy and venous graft disease. Current Opinion In Cardiology 1998, 13: 459. PMID: 9822880, DOI: 10.1097/00001573-199811000-00012.Peer-Reviewed Original ResearchConceptsVenous graft diseaseGraft diseaseLow-dose oral anticoagulationAggressive cholesterol reductionEfficacy of antithromboticsCoronary artery bypassSymptom-free survivalTiming of therapyPotent antithrombotic agentOral anticoagulationAntithrombotic therapyArtery bypassGraft occlusionPreventive therapyAntiplatelet agentsHemostatic factorsAntithrombotic agentsCholesterol reductionTherapyFirst dayPatientsSurgeryDisease developmentDiseaseFirst year